Pediatric Pulmonary Vascular Disease or Adult Pulmonary Vascular Disease

Potential Roles of Metals in the Pathogenesis of Pulmonary and Systemic Hypertension

C. Danielle Hopkins, Caitlin Wessel, Oscar Chen, Karim El-Kersh, Matthew C. Cave, Lu Cai, Jiapeng HuangUniversity of Louisville School of Medicine. University of Nebraska Medical Center. Jewish Hospital Trager Transplant Center. United States International Journal of Biological SciencesInt J Biol Sci 2023; 19: 5036-5054DOI: 10.7150/ijbs.85590 AbstractPulmonary and systemic hypertension (PH, SH) are characterized by vasoconstriction and […]

Potential Roles of Metals in the Pathogenesis of Pulmonary and Systemic Hypertension Read More »

Repair of congenital and acquired pulmonary vein stenosis

Jacques A. M. van Son, Gordon K. Danielson, Francisco J. Puga, William D. Edwards, David J. DriscollMayo Clinic.United States Annals of Thoracic SurgeryAnn Thorac Surg 1995; 60: 144-150DOI: 10.1016/0003-4975(95)00325-f AbstractBackground: Congenital pulmonary vein stenosis is a rare cause of obstruction of pulmonary venous blood flow with a high mortality. Acquired pulmonary vein stenosis is an equally serious condition.Methods: Eight patients (age range,

Repair of congenital and acquired pulmonary vein stenosis Read More »

Characterization of pulmonary arterial stiffness using cardiac MRI

Michael T. Cain, Michal Schäfer, Sarah Park, Alex J. Barker, Daniel Vargas, Kurt R. Stenmark, Yen-Rei A. Yu, Todd M. Bull, D. Dunbar Ivy, Jordan R. H. HoffmanChildren’s Hospital Colorado and University of Colorado.United States International Journal of Cardiovascular ImagingInt J Cardiovasc Imaging 2023; DOI: 10.1007/s10554-023-02989-6 AbstractPulmonary arterial stiffness (PAS) is a pathologic hallmark of all

Characterization of pulmonary arterial stiffness using cardiac MRI Read More »

Advances in the research of sulfur dioxide and pulmonary hypertension

Xin Liu, He Zhou, Hongsheng Zhang, Hongfang Jin, Yan HeBeijing Anzhen Hospital and Capital Medical University. Tulane University School of Medicine. Peking University First Hospital and Peking University.China and United States Frontiers in PharmacologyFront Pharmacol 2023; 14:DOI: 10.3389/fphar.2023.1282403 AbstractPulmonary hypertension (PH) is a fatal disease caused by progressive pulmonary vascular remodeling (PVR). Currently, the mechanisms underlying

Advances in the research of sulfur dioxide and pulmonary hypertension Read More »

Technical problems in lung allotransplantation. Causes of pulmonary venous outflow obstruction

Gary H. Stevens, Decio M. Rangel, Yozo Yakeishi, Eric W. FonkalsrudUCLA School of Medicine.United States Archives of SurgeryArch Surg 1969; 99: 506-512DOI: 10.1001/archsurg.1969.01340160086020 AbstractExperience in this laboratory with approximately 100 canine and primate lung allotransplantation operations over the past 18 months has made clear the fact that technical problems are the cause of a large number

Technical problems in lung allotransplantation. Causes of pulmonary venous outflow obstruction Read More »

A very rare cause of pre-capillary pulmonary hypertension: The PAMI syndrome

Manuela Iseppi, Giulio Savonitto, Alberto Tommasini, Alessia Pin, Gianfranco Sinagra, Davide Stolfozienda Sanitaria Universitaria Giuliano-Isontina (ASUGI) and University of Trieste. University of Verona. Karolinska Institutet.Italy and Sweden Pulmonary CirculationPulm Circ 2023; 13: DOI: 10.1002/pul2.12300 AbstractWe report the first known case of PAMI syndrome associated with pulmonary arterial hypertension (PAH) with a positive response to cyclophosphamide and

A very rare cause of pre-capillary pulmonary hypertension: The PAMI syndrome Read More »

Efficacy of a Commercial Physical Activity Monitor in Longitudinal Tracking of Patients With Pulmonary Hypertension: A Pilot Study

Eliana Rosenzweig, Gerson Antonio Valencia Villeda, Sarah Crook, Fatima Koli, Erika B. Rosenzweig, Usha S. KrishnanColumbia University Irving Medical Center and New York Presbyterian Hospital. Orlando Health Arnold Palmer Hospital for Children.United States Texas Heart Institue JournalTex Heart Inst J 2023; 50DOI: 10.14503/THIJ-22-7866 AbstractBackground: Patients with pulmonary arterial hypertension have quality-of-life limitations, decreased exercise capacity, and poor

Efficacy of a Commercial Physical Activity Monitor in Longitudinal Tracking of Patients With Pulmonary Hypertension: A Pilot Study Read More »

Fenestration: Integrating Wings Into the Atrial Septal Occluder for Navigating a Challenging Terrain

Anil K. Singhi, Soumya K. Mohapatra, Dilip Kumar, Arindam Pande, Ashesh Halder, Somnath Dey, Anish Nath, Arnab DeMedica Superspecialty Hospital. India CureusCureus 2023; 15DOI: 10.7759/cureus.45260 AbstractBackground: Atrial septal defect (ASD) closure with significant left-to-right shunt and concurrent comorbidities poses challenges for intervention. A fenestrated atrial septal defect (FASD) device is a viable option for patients who

Fenestration: Integrating Wings Into the Atrial Septal Occluder for Navigating a Challenging Terrain Read More »

Exercise-Induced Electrocardiography Changes in Pulmonary Arterial Hypertension

Maya Kailas, Aimee M. Layton, Meredith Pesce, Leonardo Liberman, Thomas J. Starc, Michael A. Fremed, Robert Garafano, Erika B. Rosenzweig, Usha S. KrishnanMount Sinai Kravis Children’s Hospital. Columbia University Irving Medical Center. Yale New Haven Hospital.United States American Journal of CardiologyAm J Cardiol 2023; 208: 60-64DOI: 10.1016/j.amjcard.2023.09.014 AbstractCardiopulmonary exercise testing (CPET) is an important tool in

Exercise-Induced Electrocardiography Changes in Pulmonary Arterial Hypertension Read More »

Pediatric lung transplantation. Indications, techniques, and early results

Thomas L. Spray, George B. Mallory, Charles B. Canter, Charles B. HuddlestonWashington University School of Medicine.United States Journal of Thoracic and Cardiovascular SurgeryJ Thorac Cardiovasc Surg 1994; 107: 990-999DOI: Not Available AbstractFrom July 1990 to April 1993, 36 lung transplantations in 33 patients were performed in our pediatric transplant program (0.25 to 23 years, mean

Pediatric lung transplantation. Indications, techniques, and early results Read More »

Scroll to Top